 |
|
|
|
|
Angel Healthcare Investors, LLC invests
in promising opportunities across all segments of the
healthcare/life sciences markets. Selected portfolio holdings
are listed below. |
|
|
Angstrom Medica, Inc.
Angstrom Medica is a biomaterials and medical device company engaged
in the development and commercialization of structural, nanocrystalline
calcium phosphate (NanOss™) based medical devices for the spinal,
sports medicine, trauma and general orthopaedics markets. NanOss™
is an innovative structural biomaterial that utilizes nanotechnology
to achieve nearly the strength of stainless steel while remaining
highly osteoconductive allowing it to remodel over time into human
bone.
www.angstrommedica.com
|
|
|
Autogenomics, Inc.
AutoGenomics will capitalize on the opportunity in molecular diagnostics
market and position the INFINITI™ Analyzer as the platform of
choice, providing unparalleled workflow improvements to the clinical
laboratory. The INFINITI™ analyzer is a fully automated multiplexing
microarray platform that delivers amplified sample to results
without manual intervention. Based on a novel film based matrix
for the microarray, available applications are in the areas of
genetic disorders (coagulation factors, CFTR, Ashkenazi Jewish
panel), pharmacogenomics (CYP450 2C9 + VKORC1, 2D6, 2C19, NAT2),
cancer (HPV genotyping) and infectious disease (MTB drug resistance).
www.autogenomics.com
|
|
|
Cambridge Endoscopic Devices, Inc.
CED has developed a line of innovative surgical instruments that
address the need for enhanced dexterity and manipulation in laparoscopic
and endoscopic surgery. These advanced instruments overcome surgical
barriers encountered with traditional endoscopic and laparoscopic
instruments, allowing for the potential of new innovative surgical
procedures and better, more cost effective clinical outcomes.
|
|
|
Kairos Partners
Kairos Partners is a series of healthcare investment partnerships
focused on microcap medical device companies making products for
critical care patients. Our focus sectors include Biomaterials,
Electrophysiology, Imaging Systems, Interventional Cardiology
and Spine-Related Orthopedics. Kairos’ leverages substantial industry
operating experience to provide Limited Partners with access to
exceptional investment opportunities they might not otherwise
have.
www.kairos-partners.com
|
|
|
Longwatch, Inc.
Longwatch, Inc. was founded by a team of industry veterans to provide
video surveillance over existing SCADA communication networks.
Longwatch is primarily focused on the water, oil & gas, and electric
power markets. The system gives operators the ability to manage both video
alarms and system alarms on the same system.
www.longwatch.com
|
|
|
Metabolix, Inc.
Metabolix is commercializing a family of polymers (PHA natural
plastics) made from renewable resources such as sugars and vegetable
oils. These high performing new materials have the potential to
put a large portion of the plastics and chemicals industry on
a sustainable basis. Metabolix’s Natural Plastics range in properties
from rigid, strong and stiff to tough and highly elastomeric to
soft and tacky, offering a renewable and environmentally friendly
alternative in many applications now served by synthetic plastics,
including fiber, film, molded goods, extruded products, adhesives,
and coatings. In November 2004, Metabolix formed an alliance for
the production of its Natural Plastics via fermentation with Archer,
Daniels, Midland, one of the world’s largest producers of agricultural
products.
www.metabolix.com
|
|
|
QUOSA, Inc.
Boston-based QUOSA, Inc. offers industry-leading software for
life-science professionals in academia, government, and pharmaceutical/biotech
companies. Called QUOSA Information Manager™, the software automates
and simplifies full-article retrieval, article organization, and
full-text searching. QUOSA also offers a companion product called
QUOSA Virtual Library™ that enables teams to easily and intelligently
share articles and other documents.
www.quosa.com
|
|
|
TyRx Pharma, Inc.
TyRx is dedicated to the innovation, development and commercialization
of high-value combination medical devices and pharmaceutical products,
utilizing robust tyrosine-based resorbable polymer systems in
collaboration with world-class partners.
www.tyrxpharma.com
|
|
|
Westfield Capital Management
(Westfield Life Sciences Fund)
Launched in July of 2000, the Westfield Life Sciences Fund invests
in healthcare companies across the capitalization spectrum including
medical devices, drugs, drug delivery, biotechnology, and healthcare
services. Portfolio manager Will Muggia employs a fundamental,
bottom up research driven process that focuses on preservation
of capital and long-term outperformance. Westfield's extensive
industry network developed by Mr. Muggia and his analytical team
is critical to new idea generation.
www.westfieldcapital.com
|
Other Active Portfolio
Holdings
- AFFINTA, Inc.
- Allegiance Hospice Group, Inc.
- Catalyst Health & Technology Partners, LP
- Claimtrust, Inc.
- Dragonvest Partners Equity Fund, LP
- Elixir Pharmaceuticals, Inc.
- GI Dynamics, Inc.
- Great Point Partners, LP
- Harbor House/Allerton House
- Iconic Therapeutics, Inc.
- Lucida Staffing Group, LLC
- LumeRx, Inc.
- Outside the Classroom, Inc.
- Seedling Enterprises, LLC
- SmartCells, Inc.
- Straus Capital Healthcare Partners
- Verification Technologies, Inc.
- Worcester Professional Baseball, LLC
|
|
|
|
